Speaker
Background
Breast cancer is one of the most commonly diagnosed malignancies among women. Postoperative radiotherapy plays an important role in reducing local recurrence and improving tumour control. However, minimizing radiation exposure to nearby critical organs, particularly the heart and ipsilateral lung, remains a major concern. Advanced radiotherapy techniques may improve treatment precision and reduce normal tissue complications.
Discussion (methods + interpretation)
Treatment plans were generated using Eclipse Treatment Planning System (Version 16.1) for a Varian linear accelerator with a 6 MV photon beam. Dosimetric parameters, including PTV coverage, heart dose, and ipsilateral lung dose, were evaluated. Radiobiological parameters, including Equivalent Uniform Dose (EUD), Tumour Control Probability (TCP), and Normal Tissue Complication Probability (NTCP), were assessed using RadBioMod software. Statistical analysis was performed using OriginPro 2024, with one-way ANOVA. Results indicated that IMRT improved dose conformity and uniformity while reducing radiation exposure to critical organs compared with 3DCRT.
Aim & Purpose
This study aimed to compare the dosimetric and radiobiological performance of Intensity-Modulated Radiotherapy (IMRT) and Three-Dimensional Conformal Radiotherapy (3DCRT) in postoperative breast cancer irradiation. The objective was to evaluate target coverage, dose conformity, organ-at-risk sparing, and radiobiological outcomes to identify the more effective treatment technique.
Result
IMRT demonstrated superior dosimetric and radiobiological performance compared with 3DCRT. It achieved improved PTV dose uniformity and conformity while reducing mean heart dose, heart V20Gy, and ipsilateral lung radiation exposure, including V20Gy. Furthermore, IMRT showed a significantly higher Tumour Control Probability (TCP) than 3DCRT (97.78 ± 0.37% vs. 95.59 ± 0.45%, respectively; p less than 0.0001). These findings suggest that IMRT provides better target coverage and improved protection of surrounding healthy organs in postoperative breast cancer radiotherapy.
| Email address | Iqrasaeed8816@gmail.com |
|---|---|
| Phone number | 0302-0738816 |